Bio-Rad Laboratories, Inc. Share Price
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
11:44:13 23/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 379.00 USD | -0.15% |
|
-0.44% | +24.54% |
| Market Cap | 1.01TCr 884.34Cr 831.28Cr 760.02Cr 1.42TCr 97TCr 1.43TCr 9.98TCr 3.87TCr 49TCr 3.78TCr 3.7TCr 1,59500Cr | P/E 2026 * |
45.6x | P/E 2027 * | 44.6x |
|---|---|---|---|---|---|
| Enterprise Value | 932.67Cr 818.6Cr 769.49Cr 703.52Cr 1.31TCr 89TCr 1.32TCr 9.24TCr 3.58TCr 46TCr 3.5TCr 3.43TCr 1,47700Cr | EV / Sales 2026 * |
3.62x | EV / Sales 2027 * | 3.46x |
| Free-Float |
60.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BIO | Delayed | |
CBOE
| BIO | Real-time | |
|
Tradegate
| BUWA | Real-time | |
|
Deutsche Boerse AG
| BUWA | Delayed | |
|
Börse Stuttgart
| BUWA | Delayed | |
|
Boerse Muenchen
| BUWA | Real-time |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | -0.05% | ||
| 1 week | -0.44% | ||
| Current month | -2.27% | ||
| 1 month | -1.16% | ||
| 3 months | +39.59% | ||
| 6 months | +42.40% | ||
| Current year | +24.54% |
| 1 week | 373.47 |  | 385.71 |
| 1 month | 365.66 | | 396.23 |
| Current year | 236.73 | | 396.23 |
| 1 year | 236.73 | | 396.23 |
| 3 years | 211.43 | | 396.23 |
| 5 years | 211.43 | | 804.65 |
| 10 years | 154.89 | | 832.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/09/26 | Exercice | General Counsel | 1,841 | 0.0085% | ||
| 06/09/26 | Exercice | Chief Executive Officer | 8,764 | 0.0404% | ||
| 06/09/26 | Exercice | Chief Financial Officer | 3,854 | 0.0178% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.15% | -0.44% | +33.78% | +6.84% | 1.01TCr | |
| +0.14% | +1.66% | -23.42% | +6.76% | 18TCr | |
| -1.78% | -3.47% | -5.87% | +11.78% | 12TCr | |
| -0.46% | -1.22% | +4.04% | +68.05% | 6TCr | |
| -0.24% | +0.59% | -1.93% | -31.43% | 4.98TCr | |
| -0.22% | +1.23% | +7.80% | +45.79% | 4.8TCr | |
| -2.40% | +0.58% | +28.81% | +2.08% | 3.38TCr | |
| -0.97% | +3.86% | - | - | 3.02TCr | |
| +0.63% | +3.19% | +48.95% | -0.54% | 2.61TCr | |
| -0.39% | +6.03% | +9.83% | -9.35% | 2.3TCr | |
| Average | -0.57% | +1.55% | +11.33% | +11.11% | 5.77TCr | |
| Weighted average by Cap. | -0.58% | +0.44% | -2.83% | +13.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 257.32Cr 225.85Cr 212.3Cr 194.1Cr 362.71Cr 25TCr 365.4Cr 2.55TCr 988.58Cr 13TCr 966.32Cr 945.14Cr 41TCr | 263.34Cr 231.13Cr 217.27Cr 198.64Cr 371.19Cr 25TCr 373.94Cr 2.61TCr 1.01TCr 13TCr 988.92Cr 967.25Cr 42TCr |
| Net income | 22Cr 20Cr 19Cr 17Cr 32Cr 2.15TCr 32Cr 222.82Cr 86Cr 1.1TCr 84Cr 83Cr 3.56TCr | 23Cr 20Cr 19Cr 17Cr 32Cr 2.2TCr 33Cr 227.65Cr 88Cr 1.12TCr 86Cr 84Cr 3.64TCr |
| Net Debt | -75Cr -66Cr -62Cr -56Cr -105.58Cr -7.17TCr -106.36Cr -742.27Cr -287.76Cr -3.66TCr -281.28Cr -275.11Cr -12TCr | -97Cr -85Cr -80Cr -73Cr -136.08Cr -9.25TCr -137.09Cr -956.72Cr -370.89Cr -4.71TCr -362.54Cr -354.6Cr -15TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | $377.22 | -0.62% | 69,868 |
| 22/26/22 | $379.57 | +0.59% | 3,74,684 |
| 21/26/21 | $377.33 | +0.24% | 3,11,465 |
| 18/26/18 | $376.41 | -1.57% | 3,24,347 |
| 17/26/17 | $382.41 | +0.89% | 2,04,960 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
Select your edition
All financial news and data tailored to specific country editions
